Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
142.20B | 135.63B | 129.29B | 109.33B | 109.64B | 117.22B | Gross Profit |
23.64B | 23.01B | 18.79B | 15.53B | 15.77B | 17.63B | EBIT |
13.51B | 12.32B | 7.83B | 5.71B | 6.62B | 8.40B | EBITDA |
14.31B | 13.59B | 8.96B | 6.75B | 7.43B | 9.16B | Net Income Common Stockholders |
8.89B | 8.22B | 5.05B | 3.79B | 4.54B | 5.59B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
14.11B | 22.10B | 11.16B | 9.35B | 9.95B | 10.46B | Total Assets |
130.13B | 130.84B | 122.12B | 116.08B | 93.10B | 95.42B | Total Debt |
20.47B | 18.56B | 20.24B | 29.89B | 10.01B | 10.62B | Net Debt |
6.36B | -3.54B | 9.07B | 20.55B | 61.00M | 160.00M | Total Liabilities |
73.19B | 72.95B | 69.95B | 68.21B | 47.57B | 53.21B | Stockholders Equity |
56.94B | 57.88B | 52.17B | 47.87B | 45.53B | 42.21B |
Cash Flow | Free Cash Flow | ||||
0.00 | 14.95B | 13.83B | -18.31B | 1.31B | -4.41B | Operating Cash Flow |
0.00 | 15.95B | 15.94B | -16.71B | 2.60B | -3.68B | Investing Cash Flow |
0.00 | -807.00M | -1.92B | -1.96B | -1.15B | -675.00M | Financing Cash Flow |
0.00 | -4.21B | -12.22B | 18.06B | -1.97B | -664.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥82.90B | 10.09 | 5.64% | 4.90% | 62.07% | ||
78 Outperform | ¥72.29B | 12.79 | 1.19% | 17.42% | -12.68% | ||
75 Outperform | ¥70.93B | 3.80 | 0.57% | -12.15% | ― | ||
74 Outperform | ¥138.15B | 16.61 | 7.89% | -7.59% | 18.77% | ||
69 Neutral | ¥106.05B | 16.15 | 3.75% | 2.61% | -9.10% | ||
66 Neutral | $4.47B | 12.21 | 5.40% | 3.65% | 4.14% | -12.00% | |
63 Neutral | ¥86.95B | 15.26 | 2.90% | 10.88% | -29.60% |